Fas ligand gene polymorphisms are not associated with Hashimoto’s thyroiditis and Graves’ disease
- 28 February 2003
- journal article
- Published by Elsevier in Human Immunology
- Vol. 64 (2) , 285-289
- https://doi.org/10.1016/s0198-8859(02)00775-9
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG Ba 976/8-2)
This publication has 20 references indexed in Scilit:
- Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseasesTrends in Endocrinology & Metabolism, 2001
- Association of a CA repeat polymorphism upstream of the Fas ligand gene with multiple sclerosisJournal of Neuroimmunology, 2001
- Differential Regulation of Fas-Mediated Apoptosis in Both Thyrocyte and Lymphocyte Cellular Compartments Correlates with Opposite Phenotypic Manifestations of Autoimmune Thyroid DiseaseThyroid®, 2001
- AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROMEPediatric Clinics of North America, 2000
- A Generalization of the Transmission/Disequilibrium Test for Uncertain-Haplotype TransmissionAmerican Journal of Human Genetics, 1999
- Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.Journal of Clinical Investigation, 1996
- An extended transmission/disequilibrium test (TDT) for multi‐allele marker lociAnnals of Human Genetics, 1995
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995
- Human Fas ligand: gene structure, chromosomal location and species specificityInternational Immunology, 1994
- DIFFERENTIATION OF THYROTOXICOSIS INDUCED BY THYROID DESTRUCTION FROM GRAVES' DISEASEThe Lancet, 1978